rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
2
|
pubmed:dateCreated |
2004-3-1
|
pubmed:abstractText |
To confirm the specific decrease of P25 protein, a novel myasthenia gravis (MG) associated protein, in myasthenia gravis (MG) patients and to study the tissue and species specificity of its expression.
|
pubmed:language |
chi
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jan
|
pubmed:issn |
0376-2491
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:day |
17
|
pubmed:volume |
84
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
103-6
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:14990122-Animals,
pubmed-meshheading:14990122-Female,
pubmed-meshheading:14990122-Humans,
pubmed-meshheading:14990122-Male,
pubmed-meshheading:14990122-Muscle, Skeletal,
pubmed-meshheading:14990122-Myasthenia Gravis,
pubmed-meshheading:14990122-Organ Specificity,
pubmed-meshheading:14990122-Proteins,
pubmed-meshheading:14990122-Receptors, Cholinergic,
pubmed-meshheading:14990122-Species Specificity
|
pubmed:year |
2004
|
pubmed:articleTitle |
[Expression and tissue and species specificity of P25 protein in patients with myasthenia gravis].
|
pubmed:affiliation |
Institute of Neurology, State Key Laboratory of Medical Neurobiology, Fudan University, Shanghai 200040, China.
|
pubmed:publicationType |
Journal Article,
English Abstract,
Research Support, Non-U.S. Gov't
|